Everand Logo

Welcome to Everand!

  • STAT

    Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178

    The drug maker Kaleo was charging $4,100 for a two-pack of an opioid overdose reversal device. After an outcry, it’s authorizing a generic for a fraction of the price.
    by Lev Facher Dec 12, 2018 2 minutes
    The auto-injector Evzio

    WASHINGTON — A month after the drug maker Kaleo came under fire from lawmakers and public-health advocates for charging $4,100 for a device that reverses overdoses, the company has announced it will introduce a generic version for a small fraction of the price.

    The company announced Wednesday it has authorized its subsidiary IJ Therapeutics to produce

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
    The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

    Related Books & Audiobooks